212 related articles for article (PubMed ID: 19689365)
41. D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity.
Grieco P; Balse PM; Weinberg D; MacNeil T; Hruby VJ
J Med Chem; 2000 Dec; 43(26):4998-5002. PubMed ID: 11150170
[TBL] [Abstract][Full Text] [Related]
42. The role of the melanocortin 3 receptor in mediating the effects of gamma-MSH peptides on the adrenal.
Harmer SC; Bicknell AB
Endocr Res; 2004 Nov; 30(4):629-35. PubMed ID: 15666803
[TBL] [Abstract][Full Text] [Related]
43. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors.
Oosterom J; Nijenhuis WA; Schaaper WM; Slootstra J; Meloen RH; Gispen WH; Burbach JP; Adan RA
J Biol Chem; 1999 Jun; 274(24):16853-60. PubMed ID: 10358030
[TBL] [Abstract][Full Text] [Related]
44. Overview of endogenous and synthetic melanocortin peptides.
Wilson KR; Todorovic A; Proneth B; Haskell-Luevano C
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):3-20. PubMed ID: 16914082
[TBL] [Abstract][Full Text] [Related]
45. Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptor.
Qu H; Cai M; Mayorov AV; Grieco P; Zingsheim M; Trivedi D; Hruby VJ
J Med Chem; 2009 Jun; 52(12):3627-35. PubMed ID: 19473029
[TBL] [Abstract][Full Text] [Related]
46. A role for MC3R in modulating lung inflammation.
Getting SJ; Riffo-Vasquez Y; Pitchford S; Kaneva M; Grieco P; Page CP; Perretti M; Spina D
Pulm Pharmacol Ther; 2008 Dec; 21(6):866-73. PubMed ID: 18992358
[TBL] [Abstract][Full Text] [Related]
47. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors. Part 3: modifications at the Arg position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
Peptides; 2003 Jan; 24(1):73-82. PubMed ID: 12576087
[TBL] [Abstract][Full Text] [Related]
48. Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents.
Chaki S; Ogawa S; Toda Y; Funakoshi T; Okuyama S
Eur J Pharmacol; 2003 Aug; 474(1):95-101. PubMed ID: 12909200
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and Structure-Activity Relationships of Substituted Urea Derivatives on Mouse Melanocortin Receptors.
Singh A; Kast J; Dirain ML; Huang H; Haskell-Luevano C
ACS Chem Neurosci; 2016 Feb; 7(2):196-205. PubMed ID: 26645732
[TBL] [Abstract][Full Text] [Related]
50. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.
Mounien L; Do Rego JC; Bizet P; Boutelet I; Gourcerol G; Fournier A; Brabet P; Costentin J; Vaudry H; Jégou S
Neuropsychopharmacology; 2009 Jan; 34(2):424-35. PubMed ID: 18536705
[TBL] [Abstract][Full Text] [Related]
51. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
[TBL] [Abstract][Full Text] [Related]
52. Identification of domains directing specificity of coupling to G-proteins for the melanocortin MC3 and MC4 receptors.
Kim CS; Lee SH; Kim RY; Kim BJ; Li SZ; Lee IH; Lee EJ; Lim SK; Bae YS; Lee W; Baik JH
J Biol Chem; 2002 Aug; 277(35):31310-7. PubMed ID: 12045190
[TBL] [Abstract][Full Text] [Related]
53. Altered sucrose self-administration following injection of melanocortin receptor agonists and antagonists into the ventral tegmental area.
Shanmugarajah L; Dunigan AI; Frantz KJ; Roseberry AG
Psychopharmacology (Berl); 2017 Jun; 234(11):1683-1692. PubMed ID: 28243712
[TBL] [Abstract][Full Text] [Related]
54. Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor.
Mayorov AV; Cai M; Palmer ES; Dedek MM; Cain JP; Van Scoy AR; Tan B; Vagner J; Trivedi D; Hruby VJ
J Med Chem; 2008 Jan; 51(2):187-95. PubMed ID: 18088090
[TBL] [Abstract][Full Text] [Related]
55. Utilize conjugated melanotropins for the earlier diagnosis and treatment of melanoma.
Cai M; Liu Z; Qu H; Fan H; Zheng Z; Hruby VJ
Eur J Pharmacol; 2011 Jun; 660(1):188-93. PubMed ID: 21315067
[TBL] [Abstract][Full Text] [Related]
56. The role of the melanocortin system and the melanocortin-4 receptor in ring dove (Streptopelia risoria) feeding behavior.
Strader AD; Schiöth HB; Buntin JD
Brain Res; 2003 Jan; 960(1-2):112-21. PubMed ID: 12505663
[TBL] [Abstract][Full Text] [Related]
57. Regulation of the Melanocortin-Sensitive Adenylate Cyclase System by N-Acylated Peptide 71-82 of Type 4 Melanocortin Receptor.
Shpakov AO; Derkach KV; Shpakova EA
Bull Exp Biol Med; 2015 Nov; 160(1):40-4. PubMed ID: 26593415
[TBL] [Abstract][Full Text] [Related]
58. alpha-MSH and gamma-MSH inhibit IL-1beta induced activation of the hypothalamic-pituitary-adrenal axis through central melanocortin receptors.
Cragnolini AB; Perelló M; Schiöth HB; Scimonelli TN
Regul Pept; 2004 Nov; 122(3):185-90. PubMed ID: 15491790
[TBL] [Abstract][Full Text] [Related]
59. Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.
Ayers KL; Glicksberg BS; Garfield AS; Longerich S; White JA; Yang P; Du L; Chittenden TW; Gulcher JR; Roy S; Fiedorek F; Gottesdiener K; Cohen S; North KE; Schadt EE; Li SD; Chen R; Van der Ploeg LHT
J Clin Endocrinol Metab; 2018 Jul; 103(7):2601-2612. PubMed ID: 29726959
[TBL] [Abstract][Full Text] [Related]
60. Novel approaches to the design of bioavailable melanotropins.
Zhou Y; Cai M
Expert Opin Drug Discov; 2017 Oct; 12(10):1023-1030. PubMed ID: 28699792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
